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Abstract 
Inflammation of the myenteric plexus of the gastrointestinal tract is a very rare 
pathological condition, with few reports in the medical literature. This pathological 
condition causes atonic gut motor dysfunction and is principally secondary to other 
diseases, being reported nearly solely as a paraneoplastic phenomenon in 
neuroendocrine lung tumors, including small cell carcinomas or neuroblastomas. In 
addition it can also be associated with disorders of the central nervous system, although 
it has rarely been described in Chagas disease. It has been named ‘idiopathic myenteric 
ganglionitis’ because no apparent causes can be demonstrated. We report the 
clinicopathologic findings of an exceptional case of a young woman affected by severe 
chronic constipation suddenly changing into acute intestinal pseudoobstruction with 
dramatic evolution. Relationships between ganglionitis, idiopathic constipation and 
acute intestinal pseudoobstruction as well as therapeutic implications are discussed. 
 
Case Report 
A 29-year-old female was admitted to our department in April 2005. She presented with a 
twelve-year history of constipation. The patient was initially treated by sacral neuromodulation [1]. The 
definitive implantation of a permanent impulse generator (Interstim 3023, Medtronic) months after was 
performed after a temporary trial period of stimulation. Electrode implantation caused no 
complications and six months later her general condition was improved. She had regained weight, 
defecations continued with a good daily rhythm withouth straining or abdominal pain. The patient 
declared to be fully satisfied by the improvement to her quality of life.  
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Suddenly, eight months after the permanent implantation, the situation dramatically changed. The 
patient had again severe constipation and abnormal abdominal distension. We performed an abdominal 
X-ray showing marked distension of the whole bowel, particularly of the colon. After a brief observation 
period, air fluid levels increased and the colon reached an enormous dilation. CT scan demonstrated no 
mechanical obstruction, there seemed to be a deteriorating intestinal pseudoocclusion (Ogilvie 
syndrome). The patient’s serious general condition and the presence of free air in the peritoneum forced 
us to operate on her. The length and volume of the colon were enormously increased and the wall was 
thin and perforated in the cecum. The terminal tract of the small bowel was also dilated. A total 
colectomy with ileorectal anastomosis was performed. 
Histological findings revealed a diffused and dense inflammatory infiltrate restricted to all myenteric 
plexuses (fig. 1, fig. 2) and to some submucosal plexuses (fig. 3), associated with degenerative features 
and concurrent loss of ganglion cells. In some plexuses, ganglion cells were absent. Inflammatory 
infiltrate was mixed in nature, being composed of lymphocytes, plasma cells and eosinophilis. 
Lymphocytes were the predominant cell types in most plexuses. The same histological findings were 
found in the terminal ileum which was apparently affected. 
Immunohistochemical study (fig. 4) revealed that most lymphocytes were CD3+ and CD4+ and 
only scattered lymphocytes were CD8+ or CD20+; a normal number and distribution of interstitial cells 
of Cajal stained with c-kit (CD117) was demonstrated. No pathological changes were observed in the 
mucosa and submucosa, with the exception of a mild and specific inflammatory infiltrate in the colonic 
mucosa. The histological findings, and particularly the presence of the just described subclasses of 
lymphocytes, allowed the diagnosis of ‘acute pseudoobstruction due to idiopathic immune-mediated 
myenteric ganglionitis’. 
Unfortunately surgery did not resolve the illness. After a period of relative healthiness, three months 
after the operation the abdomen was again dilated and the peristalsis stopped. New air fluid levels were 
present on X-ray. No evidence of mechanical obstruction was present on CT scan. Rectoscopy 
confirmed perviety of the ileorectal anastomosis done in the previous operation. The patient was given 
total parenteral nutrition and at the same time we attempted a course of pulse-dosed steroid treatment 
(100 mg i.v. methylprednisolone daily for ten days). The patient did not get any benefit and her clinical 
condition deteriorated. We attempted a jejunostomy to obtain decompression of the small bowel, but 
the patient’s condition quickly worsened until she eventually died. 
Discussion 
Although the cause of idiopathic severe chronic constipation has never been 
completely clarified, almost all pathological clues have been described to be of 
degenerative character and/or alterations of the neuropeptide levels. An underlying 
inflammatory neuropathy may be responsible for chronic constipation/megacolon, 
usually secondary as in Chagas and paraneoplastic diseases. Recently, idiopathic forms of 
chronic constipation/megacolon have been described with autoimmune enteric 
ganglionitis underlying chronic idiopathic constipation and subsequent megacolon [2]. 
Chronic intestinal pseudoobstruction, characterized by a loss or failure of intestinal 
peristalsis without organic causes occluding the lumen, appears to be characterized by 
frequent pseudoocclusive episodes, which can simulate mechanical occlusion. In chronic 
intestinal pseudoobstruction also different pathological clues have been noticed. The clues 
affect either the myogenic and/or the neurogenic part of the intestinal wall in 
mitochondrial myopathies and in progressive systemic sclerosis; more frequently an 
enteric ganglionitis can be secondary to different conditions, including inflammatory and 
paraneoplastic disease, or more rarely can be idiophatic [3]. 
Because of recent reports in literature [2, 3] we speculate that in our case, ganglionitis 
of the myenteric plexus was present since the first observation with clinical signs of 
chronic constipation/megacolon with a subsequent ‘dramatic’ change into an acute 
pseudoobstruction, because of the worsening of the autoimmune inflammation. This 
consideration gives us interesting perspectives in the treatment of severe constipation.  
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Pharmacological treatment of severe idiopathic chronic constipation (and of chronic 
pseudoobstruction) is reported in the scientific literature with various types of 
prokinetics: cisapride, metoclopramide, domperidone, octreotide, prostigmina, 
erythromycin, etc. However, the disordered motility is resistant to treatment and 
prokinetic drug therapy is generally disappointing. Recently some encouraging results 
have been reported regarding the first experiences in treatment by sacral 
neuromodulation [1]. If the cause of severe chronic constipation is an autoimmune 
ganglionitis, we can also attempt immunosuppressive therapy [4, 5]. In hindsight, we 
should suspect intestinal ganglionitis as a cause of severe constipation. 
Nowadays, a secure diagnosis concerning the existence of enteric ganglionitis can be 
confirmed only by histological sampling from full-thickness samples of the intestinal wall, 
and this is possible, except for the rectum, only in patients undergoing intestinal surgery. 
Antineuronal circulating antibodies, such as the antineuronal antinuclear ANNA-1, the 
anti-HU (antineuronal nuclear antibody), the anti-YO (anti Purkinje cell protein 
cytoplasmatic antibody) or other circulating antineuronal antibodies expressed in 
ganglionitis, are not reliable for diagnosis. However, in presence of any suspicion when 
intestinal occlusion is not secondary to mechanical causes, we should not hesitate to 
obtain a full-thickness biopsy of the intestinal wall, even if surgery is required. This way a 
short operation can avoid a long series of useless surgical procedures. Once we have a 
firm diagnosis, patients can benefit immediately from immunosuppressive treatment with 
high-dosed steroids and/or immunosuppressive drugs, also in association with permanent 
sacral nerve stimulation, which can help patients with complete failure of intestinal 
motility. 
Conclusion 
The reported case is exceptionally rare, in fact we found only one analogous case of 
mortality in a young adult due to acute intestinal pseudoocclusion with known primary 
visceral myopathy [6] in the literature. However we can draw some conclusions: 
(1) When severe chronic constipation is present, we must consider that this can be due to 
an inflammatory process of the myenteric plexus and thus might evolve into severe 
pseudoocclusion. (2) Only a full-thickness biopsy can offer a firm diagnosis: if we suspect 
ganglionitis we should try absolutely to obtain it. (3) With a firm diagnosis of ganglionitis 
we can treat the disease in time, not only during the exacerbation but also in the chronic 
stadium, by high doses of corticosteroids [4, 5], NPT, etc. (4) In a part of rare perforative 
complications, surgery is not indicated in intestinal pseuodoocclusion, except for 
full-tickness biopsy or decompressive procedures. 
 
 
 
 
  
Case Rep Gastroenterol 2008;2:461–468 
DOI: 10.1159/000164309 
Published online: November 19, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
464
Fig. 1. Myenteric plexus with severe inflammatory infiltrate. Inflammatory cells are present both at the 
periphery and within the plexus in direct contact with Schwann and residual ganglion cells (arrows) 
showing degenerative changes. 
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Fig. 2. High magnification of myenteric plexus showing lymphocytes, plasma cells and eosinophils. 
Residual damaged ganglion cells are still preserved (arrow). 
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Fig. 3. Submucosal plexus showing inflammatory infiltrate; some lymphocytes invade the cytoplasm of 
ganglion cells (arrow). 
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Fig. 4. Myenteric plexus. Immunohistochemical staining with CD3 antibody showing that most 
lymphocytes are T in nature. 
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